ID   MGAT1_RAT               Reviewed;         447 AA.
AC   Q09325;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   24-JUL-2024, entry version 153.
DE   RecName: Full=Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase;
DE            EC=2.4.1.101;
DE   AltName: Full=N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I;
DE            Short=GNT-I;
DE            Short=GlcNAc-T I;
GN   Name=Mgat1; Synonyms=Gnt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=7764514; DOI=10.1271/bbb.58.200;
RA   Fukada T., Iida K., Kioka N., Sakai H., Komano T.;
RT   "Cloning of a cDNA encoding N-acetylglucosaminyltransferase I from rat
RT   liver and analysis of its expression in rat tissues.";
RL   Biosci. Biotechnol. Biochem. 58:200-201(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Initiates complex N-linked carbohydrate formation. Essential
CC       for the conversion of high-mannose to hybrid and complex N-glycans.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(4)-(alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-
CC         (1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-
CC         beta-D-GlcNAc)-L-asparaginyl-[protein] (N-glucan mannose isomer
CC         5A1,2) + UDP-N-acetyl-alpha-D-glucosamine = H(+) + N(4)-{beta-D-
CC         GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-
CC         (1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-
CC         beta-D-GlcNAc}-L-asparaginyl-[protein] + UDP; Xref=Rhea:RHEA:11456,
CC         Rhea:RHEA-COMP:14367, Rhea:RHEA-COMP:14368, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57705, ChEBI:CHEBI:58223, ChEBI:CHEBI:59087,
CC         ChEBI:CHEBI:60625; EC=2.4.1.101;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=The cofactor is mostly bound to the substrate. {ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Interacts with MGAT4D. Interacts with BRI3 (By similarity).
CC       {ECO:0000250|UniProtKB:P26572, ECO:0000250|UniProtKB:P27808}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type II
CC       membrane protein. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:P26572}. Note=Co-localizes with BRI3 at the
CC       perinuclear region. {ECO:0000250|UniProtKB:P26572}.
CC   -!- TISSUE SPECIFICITY: Appears to be present in all tissues.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 13 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16302; BAA03807.1; -; mRNA.
DR   EMBL; BC074010; AAH74010.1; -; mRNA.
DR   PIR; JC2076; JC2076.
DR   RefSeq; NP_110488.1; NM_030861.1.
DR   RefSeq; XP_006246244.1; XM_006246182.3.
DR   RefSeq; XP_006246245.1; XM_006246183.3.
DR   RefSeq; XP_006246246.1; XM_006246184.3.
DR   RefSeq; XP_006246247.1; XM_006246185.3.
DR   RefSeq; XP_008765937.1; XM_008767715.2.
DR   AlphaFoldDB; Q09325; -.
DR   SMR; Q09325; -.
DR   IntAct; Q09325; 1.
DR   STRING; 10116.ENSRNOP00000068827; -.
DR   CAZy; GT13; Glycosyltransferase Family 13.
DR   iPTMnet; Q09325; -.
DR   PhosphoSitePlus; Q09325; -.
DR   jPOST; Q09325; -.
DR   PaxDb; 10116-ENSRNOP00000044560; -.
DR   Ensembl; ENSRNOT00000052360.2; ENSRNOP00000044560.1; ENSRNOG00000068826.1.
DR   Ensembl; ENSRNOT00000093956.1; ENSRNOP00000081587.1; ENSRNOG00000068826.1.
DR   Ensembl; ENSRNOT00000100116.1; ENSRNOP00000083147.1; ENSRNOG00000068826.1.
DR   Ensembl; ENSRNOT00000101283.1; ENSRNOP00000081858.1; ENSRNOG00000068826.1.
DR   Ensembl; ENSRNOT00000106126.1; ENSRNOP00000090215.1; ENSRNOG00000068826.1.
DR   Ensembl; ENSRNOT00000113892.1; ENSRNOP00000079270.1; ENSRNOG00000068826.1.
DR   Ensembl; ENSRNOT00000116725.1; ENSRNOP00000082878.1; ENSRNOG00000068826.1.
DR   Ensembl; ENSRNOT00055030999; ENSRNOP00055024983; ENSRNOG00055018286.
DR   Ensembl; ENSRNOT00055031006; ENSRNOP00055024989; ENSRNOG00055018286.
DR   Ensembl; ENSRNOT00055031011; ENSRNOP00055024994; ENSRNOG00055018286.
DR   Ensembl; ENSRNOT00055031027; ENSRNOP00055025008; ENSRNOG00055018286.
DR   Ensembl; ENSRNOT00055031033; ENSRNOP00055025014; ENSRNOG00055018286.
DR   Ensembl; ENSRNOT00055031037; ENSRNOP00055025018; ENSRNOG00055018286.
DR   Ensembl; ENSRNOT00055031046; ENSRNOP00055025027; ENSRNOG00055018286.
DR   Ensembl; ENSRNOT00060031138; ENSRNOP00060025238; ENSRNOG00060018162.
DR   Ensembl; ENSRNOT00060031156; ENSRNOP00060025254; ENSRNOG00060018162.
DR   Ensembl; ENSRNOT00060031166; ENSRNOP00060025264; ENSRNOG00060018162.
DR   Ensembl; ENSRNOT00060031183; ENSRNOP00060025281; ENSRNOG00060018162.
DR   Ensembl; ENSRNOT00060031187; ENSRNOP00060025285; ENSRNOG00060018162.
DR   Ensembl; ENSRNOT00060031194; ENSRNOP00060025292; ENSRNOG00060018162.
DR   Ensembl; ENSRNOT00060031218; ENSRNOP00060025315; ENSRNOG00060018162.
DR   Ensembl; ENSRNOT00065008954; ENSRNOP00065006373; ENSRNOG00065005942.
DR   Ensembl; ENSRNOT00065008956; ENSRNOP00065006375; ENSRNOG00065005942.
DR   Ensembl; ENSRNOT00065008957; ENSRNOP00065006376; ENSRNOG00065005942.
DR   Ensembl; ENSRNOT00065008959; ENSRNOP00065006377; ENSRNOG00065005942.
DR   Ensembl; ENSRNOT00065008962; ENSRNOP00065006380; ENSRNOG00065005942.
DR   Ensembl; ENSRNOT00065008963; ENSRNOP00065006381; ENSRNOG00065005942.
DR   Ensembl; ENSRNOT00065008965; ENSRNOP00065006383; ENSRNOG00065005942.
DR   GeneID; 81519; -.
DR   KEGG; rno:81519; -.
DR   UCSC; RGD:620097; rat.
DR   AGR; RGD:620097; -.
DR   CTD; 4245; -.
DR   RGD; 620097; Mgat1.
DR   eggNOG; KOG1413; Eukaryota.
DR   GeneTree; ENSGT00530000063632; -.
DR   HOGENOM; CLU_022150_0_0_1; -.
DR   InParanoid; Q09325; -.
DR   OMA; KGYDLSW; -.
DR   OrthoDB; 4580at2759; -.
DR   PhylomeDB; Q09325; -.
DR   TreeFam; TF320555; -.
DR   Reactome; R-RNO-964739; N-glycan trimming and elongation in the cis-Golgi.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:Q09325; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000031208; Expressed in thymus and 19 other cell types or tissues.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; ISO:RGD.
DR   GO; GO:0003827; F:alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; ISO:RGD.
DR   GO; GO:0030145; F:manganese ion binding; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IBA:GO_Central.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; ISO:RGD.
DR   GO; GO:0006049; P:UDP-N-acetylglucosamine catabolic process; ISO:RGD.
DR   CDD; cd02514; GT13_GLCNAC-TI; 1.
DR   Gene3D; 3.10.180.20; N-Acetylglucosaminyltransferase I, Domain 2; 1.
DR   InterPro; IPR004139; Glyco_trans_13.
DR   InterPro; IPR052261; Glycosyltransferase_13.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR10468:SF0; ALPHA-1,3-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE; 1.
DR   PANTHER; PTHR10468; PROTEIN O-LINKED-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE 1/ALPHA-1,3-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE; 1.
DR   Pfam; PF03071; GNT-I; 1.
DR   SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; Disulfide bond; Glycosyltransferase; Golgi apparatus; Manganese;
KW   Membrane; Metal-binding; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..447
FT                   /note="Alpha-1,3-mannosyl-glycoprotein 2-beta-N-
FT                   acetylglucosaminyltransferase"
FT                   /id="PRO_0000191386"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..29
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..447
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        291
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255"
FT   BINDING         117
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         144
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         190
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         212
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         213
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         322
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   DISULFID        115..145
FT                   /evidence="ECO:0000250"
FT   DISULFID        239..305
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   447 AA;  51586 MW;  1AB54107072C53A2 CRC64;
     MLKKQSAGLV LWGAIIFVGW NALLLLFFWT RPAPGRLPSD SALGDDPASL TREVIHLAED
     AEAELERQRG LLQQIKEHYS LWRQRWRVPT VAPPAWPRVP GTPSPAVIPI LVIACDRSTV
     RRCLDKLLHY RPSAEHFPII VSQDCGHEET AQVIASYGTA VTHIRQPDLS NIAVQPDHRK
     FQGYYKIARH YRWALGQIFN KFKFPAAVVV EDDLEVAPDF FEYFQATYPL LKADPSLWCV
     SAWNDNGKEQ MVDSSKPELL YRTDFFPGLG WLLLADLWAE LEPKWPKAFW DDWMRRPEQR
     KGRACIRPEI SRTMTFGRKG VSHGQFFDQH LKFIKLNQQF VPFTQLDLSY LQREAYDRDF
     LAQVYGAPQL QVEKVRTNDR KELGEVRVQY TSRDSFKAFA KALGVMDDLK SGVPRAGYRG
     IVTFQFRGRR VHLAPPETWN GYDPSWN
//
